A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants

There is considerable interest in therapeutic transfer of regulatory T cells (Tregs) for controlling aberrant immune responses. Initial clinical trials have shown the safety of Tregs in hematopoietic stem cell transplant recipients and subjects with juvenile diabetes. Our hypothesis is that infusion...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathew, James M., H.-Voss, Jessica, LeFever, Ann, Konieczna, Iwona, Stratton, Cheryl, He, Jie, Huang, Xuemei, Gallon, Lorenzo, Skaro, Anton, Ansari, Mohammed Javeed, Leventhal, Joseph R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943280/
https://www.ncbi.nlm.nih.gov/pubmed/29743501
http://dx.doi.org/10.1038/s41598-018-25574-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943280/
https://www.ncbi.nlm.nih.gov/pubmed/29743501
http://dx.doi.org/10.1038/s41598-018-25574-7

Ejemplares similares